HBsAg-positive for more than 6 months (HBeAg-positive or HBeAg-negative).
Age > 20 y/o.
Under lamivudine/adefovir treatment for more than 1 year due to previous lamivudine resistance (LAM-R), current HBV DNA is undetectable (< 20 IU/ml) during enrollment.

NCT01491295_inc_T1
Measurement
HBsAg
NCT01491295_inc_T2
Value
positive
NCT01491295_inc_T3
Temporal
more than 6 months
NCT01491295_inc_T4
Measurement
HBeAg
NCT01491295_inc_T5
Value
positive
NCT01491295_inc_T6
Measurement
HBeAg
NCT01491295_inc_T7
Value
negative
NCT01491295_inc_T8
Scope
HBeAg-positive or HBeAg-negative
NCT01491295_inc_T9
Person
Age
NCT01491295_inc_T10
Value
> 20 y/o
NCT01491295_inc_T11
Drug
lamivudine
NCT01491295_inc_T12
Drug
adefovir
NCT01491295_inc_T13
Temporal
more than 1 year
NCT01491295_inc_T14
Observation
lamivudine resistance
NCT01491295_inc_T15
Observation
LAM-R
NCT01491295_inc_T16
Measurement
HBV DNA
NCT01491295_inc_T17
Value
undetectable
NCT01491295_inc_T18
Value
< 20 IU/ml
NCT01491295_inc_T19
Temporal
during enrollment
NCT01491295_inc_T20
Reference_point
enrollment
NCT01491295_inc_T21
Scope
lamivudine/adefovir